Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues.

Carbonneil C.

Value Health. 2017 Jan;20(1):178-179. doi: 10.1016/j.jval.2016.09.2400. No abstract available.

2.

Organisational impact: Definition and assessment methods for medical devices.

Roussel C, Carbonneil C, Audry A; participants of Giens XXXI, Round Table No. 4.

Therapie. 2016 Feb;71(1):69-96. doi: 10.1016/j.therap.2016.01.003. Epub 2016 Feb 3. Review. English, French.

PMID:
27080633
3.

Assessment and non-clinical impact of medical devices.

Dervaux B, Szwarcensztein K, Josseran A; participants of round table N°4 of Giens XXX:, Barna A, Carbonneil C, Chevrie K, Debroucker F, Grumblat A, Grumel O, Massol J, Maugendre P, Méchin H, Orlikowski D, Roussel C, Rumeau-Pichon C, Sales JP, Vicaut E.

Therapie. 2015 Jan-Feb;70(1):57-68. doi: 10.2515/therapie/2015004. Epub 2015 Mar 6. English, French.

PMID:
25747839
4.

Evaluation et impact non clinique des dispositifs médicaux.

Dervaux B, Szwarcensztein K, Josseran A; et les participants à la table ronde N°4 de Giens XXX :, Barna A, Carbonneil C, Chevrie K, Debroucker F, Grumblat A, Grumel O, Massol J, Maugendre P, Méchin H, Orlikowski D, Roussel C, Rumeau-Pichon C, Sales JP, Vicaut E.

Therapie. 2015 Jan-Feb;70(1):57-62. doi: 10.2515/therapie/2015002. French. No abstract available.

PMID:
27393397
5.

Post-approval studies in France, challenges facing medical devices.

Levesque K, Coqueblin C, Guillot B; participants of round table n3 of Giens XXIX : Aubourg Lucie 4 Avouac Bernard 5 Carbonneil Cédric 6, Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N.

Therapie. 2014 Jul-Aug;69(4):303-21. doi: 10.2515/therapie/2014051. Epub 2014 Aug 12. English, French.

PMID:
25230354
6.

Les études post-inscriptions en France, quels enjeux pour les dispositifs médicaux.

Levesque K, Coqueblin C, Guillot B; et les participants à la table ronde N°3 de Giens XXIX, Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N.

Therapie. 2014 Jul-Aug;69(4):303-12. doi: 10.2515/therapie/2014047. French. No abstract available.

PMID:
27393225
7.

Scientific evaluation and pricing of medical devices and associated procedures in France.

Gilard M, Debroucker F, Dubray C; Participants of round table N°1 of Giens Workshops XXVIII(th), Allioux Y, Aper E, Barat-Leonhardt V, Brami M, Carbonneil C, Chartier-Kastler E, Coqueblin C, Fare S, Giri I, Goehrs JM, Levesque K, Maugendre P, Parquin F, Sales JP, Szwarcensztein K.

Therapie. 2013 Jul-Aug;68(4):193-208. doi: 10.2515/therapie/2013036. Epub 2013 Aug 28. English, French.

8.

Évaluation scientifique et tarification des dispositifs médicaux et des actes associés en France.

Gilard M, Debroucker F, Dubray C; les participants à la table ronde N° 1 de Giens XXVIII :, Allioux Y, Aper E, Barat-Leonhardt V, Brami M, Carbonneil C, Chartier-Kastler E, Coqueblin C, Fare S, Giri I, Goehrs JM, Levesque K, Maugendre P, Parquin F, Sales JP, Szwarcensztein K.

Therapie. 2013 Jul-Aug;68(4):193-200. doi: 10.2515/therapie/2013034. French. No abstract available.

PMID:
27392723
9.

Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies.

Quentin F, Carbonneil C, Moty-Monnereau C, Berti E, Goettsch W, Lee-Robin SH; European network for Health Technology Assessment (EUnetHTA).

Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:68-74. doi: 10.1017/S0266462309990705.

PMID:
20030893
10.

A common policy framework for evidence generation on promising health technologies.

Carbonneil C, Quentin F, Lee-Robin SH; European network for Health Technology Assessment (EUnetHTA).

Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:56-67. doi: 10.1017/S0266462309990699. Review.

PMID:
20030892
11.

Differential modulation of CCR5-tropic human immunodeficiency virus-1 transfer from macrophages towards T cells under interleukin-4/interleukin-13 microenvironment.

Saïdi H, Carbonneil C, Magri G, Eslahpazir J, Sekaly RP, Bélec L.

Hum Immunol. 2010 Jan;71(1):1-13. doi: 10.1016/j.humimm.2009.08.011.

PMID:
19706316
12.

Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.

Saïdi H, Magri G, Carbonneil C, Bouhlal H, Hocini H, Belec L.

AIDS Res Hum Retroviruses. 2009 May;25(5):497-509. doi: 10.1089/aid.2008.0156.

PMID:
19397398
13.

Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.

Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, Chen S, Cosentino L, Curtis K, Dezzutti CS, Donoval B, Doncel GF, Donaghay M, Grivel JC, Guzman E, Hayes M, Herold B, Hillier S, Lackman-Smith C, Landay A, Margolis L, Mayer KH, Pasicznyk JM, Pallansch-Cokonis M, Poli G, Reichelderfer P, Roberts P, Rodriguez I, Saidi H, Sassi RR, Shattock R, Cummins JE Jr.

Anal Chem. 2008 Jun 15;80(12):4741-51. doi: 10.1021/ac702628q. Epub 2008 May 17.

14.

Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Eslahpazir J, Jenabian MA, Bouhlal H, Hocini H, Carbonneil C, Grésenguet G, Mbopi Kéou FX, LeGoff J, Saïdi H, Requena M, Nasreddine N, de Dieu Longo J, Kaveri SV, Bélec L.

Clin Vaccine Immunol. 2008 May;15(5):872-84. doi: 10.1128/CVI.00463-07. Epub 2008 Mar 19.

15.

Differential modulation of human lactoferrin activity against both R5 and X4-HIV-1 adsorption on epithelial cells and dendritic cells by natural antibodies.

Saidi H, Eslahpazir J, Carbonneil C, Carthagena L, Requena M, Nassreddine N, Belec L.

J Immunol. 2006 Oct 15;177(8):5540-9. Erratum in: J Immunol. 2006 Dec 15;177(12):8879. Eslaphazir, Jobin [corrected to Eslahpazir, Jobin].

16.

IFN-gamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells.

Saïdi H, Magri G, Carbonneil C, Nasreddine N, Réquena M, Bélec L.

J Leukoc Biol. 2007 Mar;81(3):642-53. Epub 2006 Sep 13.

PMID:
16971466
17.

[Chemical barriers for the prevention of HIV and sexually transmitted infections: overview on microbicide development].

Bélec L, Saïdi H, Carbonneil C.

Med Mal Infect. 2005 Jun;35 Suppl 2:S105-7. French. No abstract available.

PMID:
15978362
18.

Natural antibodies sustain differentiation and maturation of human dendritic cells.

Bayry J, Lacroix-Desmazes S, Donkova-Petrini V, Carbonneil C, Misra N, Lepelletier Y, Delignat S, Varambally S, Oksenhendler E, Lévy Y, Debré M, Kazatchkine MD, Hermine O, Kaveri SV.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14210-5. Epub 2004 Sep 20.

19.

Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y.

Blood. 2004 Nov 15;104(10):3249-56. Epub 2004 Jul 22.

PMID:
15271794
21.
22.

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.

Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L.

AIDS. 2003 Aug 15;17(12):1731-40.

PMID:
12891059
23.

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin.

Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV.

Blood. 2003 Jan 15;101(2):758-65. Epub 2002 Aug 29.

PMID:
12393386

Supplemental Content

Loading ...
Support Center